<DOC>
	<DOCNO>NCT02876159</DOCNO>
	<brief_summary>This prospective pilot study design suggest difference immunologic response seasonal influenza vaccine people regular vaccination history compare vaccinate less regularly . Participants receive one dose Food Drug Administration ( FDA ) approve 2016-2017 seasonal influenza vaccine . Immune system data collect standard time point . The duration study participant approximately 1 month .</brief_summary>
	<brief_title>The Immunologic Basis Attenuated Immune Response Influenza Vaccine After Repeated Annual Vaccination</brief_title>
	<detailed_description>This prospective pilot study 20 male non-pregnant female , 20 30 year old , inclusive , good health meet eligibility criterion . The study design evaluate difference immunologic response seasonal influenza vaccine people regular vaccination history compare vaccinate less regularly . Participants sort either Arm A ( Na√Øve ) Arm B ( Experienced ) base vaccination history . Those vaccinate 2 past 5 year Arm A . Those vaccinate 3 past 5 year Arm B . Participants receive one dose Food Drug Administration ( FDA ) approve 2016-2017 seasonal influenza vaccine . The duration study participant approximately 1 month . Subjects return clinic visit Days 3 , 8 , 15 , 29 month follow-up period follow vaccination . The study two primary objective ; evaluate antibody response influenza vaccine people vaccinate regularly vaccinate less regularly ; second evaluate circulate follicular helper T cell ( TFH ) people vaccinate regularly vaccinate less regularly .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Capable informed consent provision write informed consent study procedure . Capable attend study visit accord study schedule . Are good health , determine medical history target physical exam related history . Oral temperature le 38 degree Celsius . Resting pulse rate 50 115 beat per minute . Female subject childbearing age must negative urine pregnancy test within 24 hour study vaccination . Have receive influenza vaccine least 3 past 5 year receive influenza vaccine 2 less past 5 year . Have acute illness within 72 hour vaccination . Have condition , opinion principal investigator , would place subject unacceptable risk injury confound interpretation study result . Have acute chronic medical condition , opinion principal investigator , would make vaccination unsafe interfere evaluation immune response study vaccination . Have suppress immune system result illness , immunosuppressive medication , chemotherapy , radiation therapy within 3 year prior study vaccination . Have know HIV , hepatitis B , hepatitis C infection . Have know history autoimmune disease . Have take oral parenteral corticosteroid dose within 30 day study vaccination . Have take highdose inhaled corticosteroid within 30 day study vaccination . Have receive licensed live vaccine within 30 day license inactivated vaccine within 14 day prior study vaccination . Have plan vaccination vaccine 29day duration subject study participation . Have receive immunoglobulin blood product , exception Rho D immunoglobulin , within 90 day prior study vaccination . Have donate blood blood product within 30 day study vaccination , plan donate blood time 29day duration subject study participation , plan donate blood within 30 day last blood draw . Have know hypersensitivity allergy egg , egg protein , chicken protein , compound study vaccine . Have history severe reaction follow vaccination influenza virus vaccine</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vaccination</keyword>
</DOC>